What does CUSIP 28106W103 represent in this 13F holders report?

CUSIP 28106W103 is the security identifier for EDIT - Editas Medicine, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held EDIT - Editas Medicine, Inc. - Common Stock in Q2 2018?

208 institutional investors reported EDIT - Editas Medicine, Inc. - Common Stock for Q2 2018. Use the holders table for investor-level position and value details.

Editas Medicine, Inc. - Common Stock (EDIT)

CUSIP: 28106W103

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock
Shares outstanding: 82,773,190
Total 13F shares: 32,137,091
Share change: +1,008,936
Total reported value: $1,150,684,888
Put/Call ratio: 108%
Price per share: $35.83
Number of holders: 208
Value change: +$38,224,646
Number of buys: 115
Number of sells: 76

Quarterly Holders Quick Answers

What is CUSIP 28106W103?
CUSIP 28106W103 identifies EDIT - Editas Medicine, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 28106W103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of EDIT - Editas Medicine, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	4.9%	4,042,657	$134,015,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	3.6%	3,016,108	$99,984,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	3.5%	2,863,624	$94,930,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	2.9%	2,394,342	$79,373,000	—	31 Mar 2018	13F
Capital World Investors	13F	Company	2.6%	2,184,000	$72,400,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	2.3%	1,883,262	$62,431,000	—	31 Mar 2018	13F
ARK Investment Management LLC	13F	Company	2%	1,620,208	$53,710,000	—	31 Mar 2018	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	1.4%	1,158,841	$38,416,000	—	31 Mar 2018	13F
VIKING GLOBAL INVESTORS LP	13F	Company	1.3%	1,035,304	$34,320,000	—	31 Mar 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.1%	892,359	$29,582,000	—	31 Mar 2018	13F
CREDIT SUISSE AG/	13F	Company	0.79%	652,081	$21,617,000	—	31 Mar 2018	13F
D. E. Shaw & Co., Inc.	13F	Company	0.66%	549,435	$18,214,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.6%	496,680	$16,462,000	—	31 Mar 2018	13F
Global Thematic Partners, LLC	13F	Company	0.57%	473,949	$15,711,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.51%	419,861	$13,917,000	—	31 Mar 2018	13F
Chevy Chase Trust Holdings, LLC	13F	Company	0.48%	393,298	$13,038,000	—	31 Mar 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.45%	373,801	$12,392,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.43%	356,981	$11,833,000	—	31 Mar 2018	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.42%	347,761	$11,528,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.41%	342,924	$11,367,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.37%	310,109	$10,280,000	—	31 Mar 2018	13F
FEDERATED HERMES, INC.	13F	Company	0.31%	255,100	$8,457,000	—	31 Mar 2018	13F
UBS Group AG	13F	Company	0.26%	214,038	$7,096,000	—	31 Mar 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.25%	205,594	$6,815,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	0.25%	203,954	$6,761,000	—	31 Mar 2018	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.23%	192,873	$6,394,000	—	31 Mar 2018	13F
PKO Investment Management Joint-Stock Co	13F	Company	0.23%	192,392	$6,377,794	—	31 Mar 2018	13F
Wildcat Capital Management, LLC	13F	Company	0.22%	185,668	$6,155,000	—	31 Mar 2018	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.22%	185,297	$6,142,000	—	31 Mar 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.22%	183,984	$6,100,000	—	31 Mar 2018	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.19%	160,961	$5,335,858	—	31 Mar 2018	13F
PDT Partners, LLC	13F	Company	0.18%	150,925	$5,003,000	—	31 Mar 2018	13F
Allianz Asset Management GmbH	13F	Company	0.17%	141,095	$4,677,000	—	31 Mar 2018	13F
Tekla Capital Management LLC	13F	Company	0.17%	137,801	$4,568,000	—	31 Mar 2018	13F
Casdin Capital, LLC	13F	Company	0.16%	133,333	$4,420,000	—	31 Mar 2018	13F
CAPITAL ADVISORS INC/OK	13F	Company	0.15%	123,774	$4,103,000	—	31 Mar 2018	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.15%	123,024	$4,078,000	—	31 Mar 2018	13F
Elmwood Wealth Management, Inc.	13F	Company	0.14%	116,877	$3,874,473	—	31 Mar 2018	13F
Man Group plc	13F	Company	0.13%	106,073	$3,516,000	—	31 Mar 2018	13F
Crestwood Advisors Group, LLC	13F	Company	0.1%	85,481	$2,834,000	—	31 Mar 2018	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.1%	84,670	$2,807,000	—	31 Mar 2018	13F
NISA INVESTMENT ADVISORS, LLC	13F	Company	0.09%	71,400	$2,367,000	—	31 Mar 2018	13F
Granahan Investment Management, LLC	13F	Company	0.09%	71,006	$2,354,000	—	31 Mar 2018	13F
CITIGROUP INC	13F	Company	0.08%	68,358	$2,267,000	—	31 Mar 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.07%	61,630	$2,044,000	—	31 Mar 2018	13F
Hudson Bay Capital Management LP	13F	Company	0.07%	60,000	$1,989,000	—	31 Mar 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.07%	56,653	$1,878,000	—	31 Mar 2018	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.07%	56,489	$1,873,000	—	31 Mar 2018	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.07%	55,882	$1,852,000	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	0.06%	51,200	$1,698,000	—	31 Mar 2018	13F

Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q2 2018

As of 30 Jun 2018, Editas Medicine, Inc. - Common Stock (EDIT) was held by 208 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,137,091 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., FMR LLC, STATE STREET CORP, Capital World Investors, ARK Investment Management LLC, MORGAN STANLEY, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Viking Global Investors LP, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 208 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

192

Q2 2018 holders

208

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.